Similar Articles |
|
The Motley Fool May 9, 2005 Stephen D. Simpson |
Integra LifeSciences Strikes a Nerve The med-tech company's missed quarter coupled with some slightly disappointing guidance caused investors to lose a bit of faith, sending the shares down more than 15% at one point. |
The Motley Fool August 2, 2006 Stephen D. Simpson |
Integra the Cyborg Mediocre underlying growth is a cause for long-term concern at the med-tech company. Investors, take note. |
The Motley Fool May 9, 2006 Stephen D. Simpson |
NeuroMetrix Has a Lot of Nerve Though an excellent opportunity, the med-tech's price has outpaced value for investors. |
The Motley Fool May 25, 2006 Stephen D. Simpson |
Same Old Patterson Even deep drilling can't unearth a discount at this dental and veterinary supply distributor. What's more aggravating is having to pay this multiple for the business. |
The Motley Fool May 4, 2006 Stephen D. Simpson |
Aspect Won't Put You to Sleep High valuation of this med-tech company all but guarantees that the stock will see some volatility. |
The Motley Fool April 20, 2006 Stephen D. Simpson |
More Predictable Unpredictability at ICU Hidden beneath all of the volatility is a pretty decent med-tech business. Recent volatility was the kind that investors like. The stock spiked up as earnings exceeded analyst estimates and the business did a fair bit better than management had projected at the end of last quarter. |
Information Today July 4, 2013 |
Innovative Interfaces Updates Encore Product EBSCO Discovery Service's full-text articles are now integrated into Encore ES along with ebooks from 3M Cloud Library and OverDrive. |
The Motley Fool May 5, 2006 Stephen D. Simpson |
FoxHollow-ed Out Worries about guidance may be giving investors a second crack at this med-tech stock. |
Investment Advisor January 2006 Ben Warwick |
The Puzzler: Trading by the Calendar The January Effect, which involves buying small-cap stocks at year end and selling them a month later, is the Elvis of investing. Has it left the building? |
The Motley Fool May 8, 2006 Stephen D. Simpson |
A Firm Backbone at Kyphon Medtronic begins a lawsuit, but Kyphon should continue to grow. However, these shares are on the expensive side, even for a fast-growing med-tech company. |
The Motley Fool November 3, 2011 Matt Koppenheffer |
Encore Capital Group Shares Dropped: What You Need to Know Shares of specialty finance company Encore Capital Group were getting trounced today, falling as much as 15% in intraday trading on news that a major shareholder is selling. |
The Motley Fool July 26, 2006 Stephen D. Simpson |
Aspect Gives Investors Nightmares The med tech company continues to grow, but high volatility is likely to follow. |
The Motley Fool January 30, 2006 Stephen D. Simpson |
Don't Hold Your Breath for Kensey Nash It's not over for Kensey Nash -- it will soon be seeing revenue from new partners Medtronic and Zimmer. But the stock's price continues to value this company as a growing med-tech idea. |
The Motley Fool February 4, 2005 Paul Elliott |
Wall Street's Worst-Kept Secret If you invest in stocks for the long term, you must own small-cap stocks. |
The Motley Fool July 27, 2006 Stephen D. Simpson |
Growth Ingrates Dump Intuitive Surgical Despite today's sell-off, Intuitive Surgical remains a red-hot grower in the med-tech space. |
The Motley Fool January 7, 2005 Paul Elliott |
Wall Street's Worst-Kept Secret If you invest in stocks for the long term, you must own small-cap stocks. |
The Motley Fool May 23, 2008 Toby Shute |
Encore Eyes the Exit This oil and gas success story may be at an end, as Encore Acquisition puts itself up for sale. |
The Motley Fool October 19, 2005 Stephen D. Simpson |
ICU, You Look Healthier An incredible third quarter shows what operating leverage can do for this little medical technology company. Investors, take note. |
The Motley Fool March 4, 2005 Paul Elliott |
Wall Street's Worst-Kept Secret Over the long haul, smaller-company stocks outperform their mid- and large-cap peers, so smart investors own them. |
The Motley Fool March 28, 2011 Travis Hoium |
Encore Capital Group Shares Plunged Temporarily: What You Need to Know Shares of Encore Capital Group didn't just plunge today. They fell off a cliff at 12:04 p.m. ET, when sellers crashed through the market. |
The Motley Fool February 8, 2011 Brian Orelli |
What Will Intuitive Surgical Do for an Encore? Intuitive Surgical managed just a 10% year-over-year increase in revenue from sales of its da Vinci Surgical Systems in the fourth quarter of last year. Yet its total revenue increased a solid 21%. How? |
Information Today May 3, 2010 Marshall Breeding |
Encore Synergy Launched for Article Discovery--A New Search Model This new enhanced version of Encore uses dynamic web services interoperability with content providers to layer access to articles into search results. |
The Motley Fool October 31, 2005 Stephen D. Simpson |
Integra Needs to Grow From Within Acquired growth is nice, but organic growth is the key to long-term success. Quite frankly, the only way this stock works from a cash flow valuation standpoint is if the company does in fact deliver very good growth over the next 10 years or so. |
The Motley Fool November 12, 2007 Mac Greer |
Fool Video: Great Stocks for Bad Markets, Disney's Next Act, and Akamai's Bright Future What are the best stocks to own in a volatile market? What will Disney do next? Will Akamai continue to deliver in the wake of Limelight's deal with Microsoft? These questions and others are answered in this video. |
The Motley Fool January 30, 2006 Stephen D. Simpson |
Respironics in Thin Air Respironics has a great business in the sleep apnea duopoly, but it's still expensive. Investors, take note. |
The Motley Fool August 21, 2006 Stephen D. Simpson |
Kensey Nash Losing the Benefit of the Doubt Med-tech investors won't wait indefinitely for growth. Investors can find better values in this sector if they're willing to roll up their sleeves for some due diligence. |
The Motley Fool July 22, 2005 Stephen D. Simpson |
Bio-Tech's Robot-Coaster Ride Intuitive Surgical is a high-growth, high-opportunity stock with a history of earnings-related volatility. |
Information Today January 21, 2010 |
Encore Discovery Offers New Article Integration Capabilities Innovative Interfaces, Inc. announced that Encore Discovery now offers deep article integration to promote the most relevant article content alongside library catalog results, making articles more findable through facets and other discovery tools. |